ÂÜÀòÂÒÂ×

Erich Platzer is an experienced board member and chairman in the biotechnology and pharmaceutical sectors, currently serving on the Board of Panavance Therapeutics Inc. since October 2021 and Aptose Biosciences, Inc. since December 2014. Platzer has held the position of Chairman of the Board at Vivoryon Therapeutics AG, focusing on Alzheimer’s disease treatments, and Léman Micro Devices, which develops smartphone-connected vital sign measurement technologies. Other significant roles include Board Member at MTIP MedTech Innovation Partners AG, StartAngels Network, and AOT Swiss, where innovative medical technologies and investment in healthtech are prioritized. With a medical doctorate from FAU Erlangen-Nürnberg and a background in mathematics and physics, Platzer has a strong foundation in both scientific and business aspects of healthcare innovation.